Comparative Study of IL-33 and IL-6 Levels in Different Respiratory Samples in Mild-to-Moderate Asthma and COPD

References

• Culpitt SV, Rogers DF, Traves SL, Barnes PJ, Donnelly LE. Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma. Respir Med 2005;99(6):703–10. https://doi.org/10.1016/j.rmed.2004.10.022.
   PubMed Web of Science ®Google Scholar
• Fabbri LM, Romagnoli M, Corbetta L, Casoni G, Busljetic K, Turato G, Ligabue G, Ciaccia A, Saetta M, Papi A. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;167(3):418–24. https://doi.org/10.1164/rccm.200203-183OC.
   PubMed Web of Science ®Google Scholar
• Górska K, Paplińska-Goryca M, Nejman-Gryz P, Goryca K, Krenke R. Eosinophilic and neutrophilic airway inflammation in the phenotyping of mild-to-moderate asthma and chronic obstructive pulmonary disease. Journal of Chronic Obstructive Pulmonary Disease. 2017; 14 (2);181–189, DOI:10.1080/15412555.2016.1260539 COPD.
   PubMed Web of Science ®Google Scholar
• Agusti A, Bel E, Thomas M, Vogelmeier C, Brusselle G, Holgate S, Humbert M, Jones P, Gibson PG, Vestbo J. Treatable traits: toward precision medicine of chronic airway diseases. Eur Respir J 2016;47(2):410–9. https://doi.org/10.1183/13993003.01359-2015.
   PubMed Web of Science ®Google Scholar
• Ghebre MA, Bafadhel, M, Desai Dhananjay, Cohen, Suzanne E. Biological clustering supports both “Dutch” and “British” hypotheses of asthma and chronic obstructive pulmonary disease – Journal of Allergy and Clinical Immunology. The Journal of Allergy and Clinical Immunology. 2015;135(1):63–72.e10. doi:10.1016/j.jaci.2014.06.035.
   Google Scholar
• Bafadhel M, McKenna S, Terry S, Mistry V, Pancholi M, Venge P, Lomas DA, Barer MR, Johnston SL, Pavord ID. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. Am J Respir Crit Care Med 2012;186(1):48–55. https://doi.org/10.1164/rccm.201108-1553OC.
   PubMed Web of Science ®Google Scholar
• Mirchandani AS, Salmond RJ, Liew FY. Interleukin-33 and the function of innate lymphoid cells. Trends Immunol 2012;33(8):389–96. https://doi.org/10.1016/j.it.2012.04.005.
   PubMed Web of Science ®Google Scholar
• Konya V, Mjösberg J. Lipid mediators as regulators of human ILC2 function in allergic diseases. Immunol Lett 2016;179:36–42. https://doi.org/10.1016/j.imlet.2016.07.006.
   PubMed Web of Science ®Google Scholar
• Kaur D, Gomez E, Doe C, Berair R, Woodman L, Saunders R, Hollins F, Rose FR, Amrani Y, May R. IL-33 drives airway hyper-responsiveness through IL-13-mediated mast cell: Airway smooth muscle crosstalk. Allergy 2015;70(5):556–67. https://doi.org/10.1111/all.12593.
   PubMed Web of Science ®Google Scholar
• Lee HY, Rhee CK, Kang JY, Byun JH, Choi JY, Kim SJ, Kim YK, Kwon SS, Lee SY. Blockade of IL-33/ST2 ameliorates airway inflammation in a murine model of allergic asthma. Exp Lung Res 2014;40(2):66–76. https://doi.org/10.3109/01902148.2013.870261.
   PubMed Web of Science ®Google Scholar
• Togbe D, Fauconnier L, Madouri F, Marchiol T, Chenuet P, Rouxel N, Ledru A, Erard F, Quesniaux V, Ryffel B. Thymic stromal lymphopoietin enhances th2/th22 and reduces il-17a in protease-allergen-induced airways inflammation. Allergy 2013; Article ID 971036, 14 pages https://doi.org/10.1155/2013/971036 ISRN Allergy 2013.
   PubMedGoogle Scholar
• Préfontaine D, Lajoie-Kadoch S, Foley S, Audusseau S, Olivenstein R, Halayko AJ, et al. Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J Immunol 2009;183(8):5094–103.
   PubMed Web of Science ®Google Scholar
• Préfontaine D, Nadigel J, Chouiali F, Audusseau S, Semlali A, Chakir J, Martin JG, Hamid Q. Increased IL-33 expression by epithelial cells in bronchial asthma. J Allergy Clin Immunol 2010;125(3):752–4. https://doi.org/10.1016/j.jaci.2009.12.935.
   PubMed Web of Science ®Google Scholar
• Shang J, Zhao J, Wu X, Xu Y, Xie J, Zhao J. Interleukin-33 promotes inflammatory cytokine production in chronic airway inflammation. Biochem Cell Biol 2015;93(4):359–66. https://doi.org/10.1139/bcb-2014-0163.
   PubMed Web of Science ®Google Scholar
• Neveu WA, Allard JL, Raymond DM, Bourassa LM, Burns SM, Bunn JY, Irvin CG, Kaminsky DA, Rincon M. Elevation of IL-6 in the allergic asthmatic airway is independent of inflammation but associates with loss of central airway function. Respir Res 2010;11:28. https://doi.org/10.1186/1465-9921-11-28.
   PubMed Web of Science ®Google Scholar
• Naik SP, P A M, B S J, Madhunapantula SV, Jahromi SR, Yadav MK. Evaluation of inflammatory markers interleukin-6 (IL-6) and matrix metalloproteinase-9 (MMP-9) in asthma. J Asthma 2016; 54(6):584–593. doi: 10.1080/02770903.2016.1244828. 1–10.
   PubMed Web of Science ®Google Scholar
• Sakthivel P, Breithaupt A, Gereke M, Copland DA, Schulz C, Gruber AD, et al. Soluble CD200 correlates with interleukin-6 levels in sera of COPD patients: potential implication of the cd200/cd200r axis in the disease course. Lung 2016;195(1):59–68. doi: 10.1007/s00408-016-9962-4.
   PubMed Web of Science ®Google Scholar
• Rincon M, Irvin CG. Role of IL-6 in asthma and other inflammatory pulmonary diseases. Int J Biol Sci 2012;8(9):1281–90. https://doi.org/10.7150/ijbs.4874.
   PubMed Web of Science ®Google Scholar
• Mazur W, Stark H, Sovijärvi A, Myllärniemi M, Kinnula VL. Comparison of 8-isoprostane and interleukin-8 in induced sputum and exhaled breath condensate from asymptomatic and symptomatic smokers. Respiration 2009;78(2):209–16.
   PubMed Web of Science ®Google Scholar
• Byers DE, Alexander-Brett J, Patel AC, Agapov E, Dang-Vu G, Jin X, Wu K, You Y, Alevy Y, Girard JP. Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease. J Clin Invest 2013;123(9):3967–82. https://doi.org/10.1172/JCI65570.
   PubMed Web of Science ®Google Scholar
• Kearley J, Silver JS, Sanden C, Liu Z, Berlin AA, White N, Mori M, Pham TH, Ward CK, Criner GJ. Cigarette smoke silences innate lymphoid cell function and facilitates an exacerbated type I interleukin-33-dependent response to infection. Immunity 2015;42(3):566–79. https://doi.org/10.1016/j.immuni.2015.02.011.
   PubMed Web of Science ®Google Scholar
• GINA_Report_2010_1.pdf. February 12, 2016. Available from: http://www.ginasthma.org/local/uploads/files/GINA_Report_2010_1.pdf
   Google Scholar
• GOLDReport_April112011.pdf. February 12, 2016. Available from: http://www.goldcopd.org/uploads/users/files/GOLDReport_April-112011.pdf
   Google Scholar
• Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P. Standardisation of spirometry. Eur Respir J 2005;26(2):319–38. https://doi.org/10.1183/09031936.05.00034805.
   PubMed Web of Science ®Google Scholar
• Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000;161(1):309–29.
   PubMed Web of Science ®Google Scholar
• Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J. Interpretative strategies for lung function tests. Eur Respir J 2005;26(5):948–68. https://doi.org/10.1183/09031936.05.00035205.
   PubMed Web of Science ®Google Scholar
• Vignola AM, Rennar SI, Hargreave FE, Fah JV, Bonsignore MR, Djukanović R, et al. Standardised methodology of sputum induction and processing. Future directions. Eur Respir J Suppl 2002;37:51s–55s.
   PubMedGoogle Scholar
• Djukanović R, Sterk PJ, Fahy JV, Hargreave FE. Standardised methodology of sputum induction and processing. Eur Respir J Suppl 2002;37:1s–2s. https://doi.org/10.1183/09031936.02.00000102.
   PubMedGoogle Scholar
• Horváth I, Hunt J, Barnes PJ, Alving K, Antczak A, Baraldi E, Becher G, van Beurden WJ, Corradi M, Dekhuijzen R. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005;26(3):523–48. https://doi.org/10.1183/09031936.05.00029705.
   PubMed Web of Science ®Google Scholar
• Górska K, Maskey-Warzęchowska M, Nejman-Gryz P, Korczyński P, Prochorec-Sobieszek M, Krenke R. Comparative study of periostin expression in different respiratory samples in patients with asthma and chronic obstructive pulmonary disease. Pol Arch Med Wewn 2016;126(3):124–37.
   PubMed Web of Science ®Google Scholar
• Gorska K, Korczynski P, Mierzejewski M, Kosciuch J, Zukowska M, Maskey-Warzechowska M, Krenke R. Comparison of endobronchial ultrasound and high resolution computed tomography as tools for airway wall imaging in asthma and chronic obstructive pulmonary disease. Respir Med 2016;117:131–8. https://doi.org/10.1016/j.rmed.2016.06.011.
   PubMed Web of Science ®Google Scholar
• Grubek-Jaworska H, Paplińska M, Hermanowicz-Salamon J, Białek-Gosk K, Dąbrowska M, Grabczak E, et al. IL-6 and IL-13 in induced sputum of COPD and asthma patients: correlation with respiratory tests. Respiration 2012;84(2):101–7.
   PubMed Web of Science ®Google Scholar
• Hastie AT, Moore WC, Li H, Rector BM, Ortega VE, Pascual RM, Peters SP, Meyers DA, Bleecker ER, National Heart. Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects. J Allergy Clin Immunol 2013;132(1):72–80. https://doi.org/10.1016/j.jaci.2013.03.044.
   PubMed Web of Science ®Google Scholar
• Berry M, Morgan A, Shaw DE, Parker D, Green R, Brightling C, Bradding P, Wardlaw AJ, Pavord ID. Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma. Thorax 2007;62(12):1043–9. https://doi.org/10.1136/thx.2006.073429.
   PubMed Web of Science ®Google Scholar
• Taylor CR, Levenson RM. Quantification of immunohistochemistry–issues concerning methods, utility and semiquantitative assessment II. Histopathology 2006;49(4):411–24. https://doi.org/10.1111/j.1365-2559.2006.02513.x.
   PubMed Web of Science ®Google Scholar
• Glück J, Rymarczyk B, Kasprzak M, Rogala B. Increased levels of interleukin-33 and thymic stromal lymphopoietin in exhaled breath condensate in chronic bronchial asthma. Int Arch Allergy Immunol 2016;169(1):51–6. https://doi.org/10.1159/000444017.
   PubMed Web of Science ®Google Scholar
• Xia J, Zhao J, Shang J, Li M, Zeng Z, Zhao J, Wang J, Xu Y, Xie J. Increased IL-33 expression in chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol 2015;308(7):L619–627. https://doi.org/10.1152/ajplung.00305.2014.
   PubMed Web of Science ®Google Scholar
• Pichery M, Mirey E, Mercier P, Lefrancais E, Dujardin A, Ortega N, et al. Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain. J Immunol 1950. 2012;188(7):3488–95.
   Google Scholar
• Drube S, Heink S, Walter S, Löhn T, Grusser M, Gerbaulet A, et al. The receptor tyrosine kinase c-Kit controls IL-33 receptor signaling in mast cells. Blood 2010;115(19):3899–906. https://doi.org/10.1182/blood-2009-10-247411.
   PubMed Web of Science ®Google Scholar
• Hayakawa H, Hayakawa M, Kume A, Tominaga S. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem 2007;282(36):26369–80. https://doi.org/10.1074/jbc.M704916200.
   PubMed Web of Science ®Google Scholar
• Liew FY, Pitman NI, McInnes IB. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol 2010;10(2):103–10. https://doi.org/10.1038/nri2692.
   PubMed Web of Science ®Google Scholar
• Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Zurawski G, Moshrefi M, Qin J, Li X. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005;23(5):479–90. https://doi.org/10.1016/j.immuni.2005.09.015.
   PubMed Web of Science ®Google Scholar
• Cayrol C, Girard J-P. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc Natl Acad Sci USA 2009;106(22):9021–6. https://doi.org/10.1073/pnas.0812690106.
   PubMed Web of Science ®Google Scholar
• Moussion C, Ortega N, Girard J-P. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel ‘alarmin’? PloS One 2008;3(10):e3331. https://doi.org/10.1371/journal.pone.0003331.
   PubMed Web of Science ®Google Scholar
• Hamzaoui A, Berraies A, Kaabachi W, Haifa M, Ammar J, Kamel H. Induced sputum levels of IL-33 and soluble ST2 in young asthmatic children. J Asthma 2013;50(8):803–9. https://doi.org/10.3109/02770903.2013.816317.
   PubMed Web of Science ®Google Scholar
• Guo Z, Wu J, Zhao J, Liu F, Chen Y, Bi L, Liu S, Dong L. IL-33 promotes airway remodeling and is a marker of asthma disease severity. J Asthma 2014;51(8):863–9. https://doi.org/10.3109/02770903.2014.921196.
   PubMed Web of Science ®Google Scholar
• Kurokawa M, Matsukura S, Kawaguchi M, Ieki K, Suzuki S, Odaka M, Watanabe S, Homma T, Sato M, Yamaguchi M. Expression and effects of IL-33 and ST2 in allergic bronchial asthma: IL-33 induces eotaxin production in lung fibroblasts. Int Arch Allergy Immunol 2011;155 Suppl 1:12–20. https://doi.org/10.1159/000327259.
   PubMed Web of Science ®Google Scholar
• Bourgeois E, Van LP, Samson M, Diem S, Barra A, Roga S, Gombert JM, Schneider E, Dy M, Gourdy P. The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production. Eur J Immunol 2009;39(4):1046–55. https://doi.org/10.1002/eji.200838575.
   PubMed Web of Science ®Google Scholar
• Paplińska-Goryca M, Nejman-Gryz P, Górska K, Białek-Gosk K, Hermanowicz-Salamon J, Krenke R. Expression of inflammatory mediators in induced sputum: comparative study in asthma and COPD. Advs Exp. Medicine, Biology - Neuroscience and Respiration 2016;1–13. DOI 10.1007/5584_2016_165
   Google Scholar
• Kim SW, Rhee CK, Kim KU, Lee SH, Hwang HG, Kim YI, Kim DK, Lee SD, Oh YM, Yoon HK. Factors associated with plasma IL-33 levels in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2017;12:395–402. https://doi.org/10.2147/COPD.S120445.
   PubMed Web of Science ®Google Scholar
• Donaldson GC, Seemungal TAR, Patel IS, Bhowmik A, Wilkinson TMA, Hurst JR, Maccallum PK, Wedzicha JA. Airway and systemic inflammation and decline in lung function in patients with COPD. Chest 2005;128(4):1995–2004. https://doi.org/10.1378/chest.128.4.1995.
   PubMed Web of Science ®Google Scholar
• He H, Tao Y, Chen X, Qiu H, Zhu J, Zhang J, et al. High levels of interleukin-6 and 8-iso-prostaglandin in the exhaled breath condensate and serum of patients with chronic obstructive pulmonary disease related pulmonary hypertension. Chin Med J (Engl) 2014;127(9):1608–12.
   PubMed Web of Science ®Google Scholar
• Moulin D, Donzé O, Talabot-Ayer D, Mézin F, Palmer G, Gabay C. Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells. Cytokine 2007;40(3):216–25. https://doi.org/10.1016/j.cyto.2007.09.013.
   PubMed Web of Science ®Google Scholar